在胃腺癌中循环瘤DNA:未来的临床应用和前景
Giulia Grizzi1, Massimiliano Salati2, Maria Bonomi1
1Oncology Unit, ASST Cremona, 26100 Cremona, Italy.
International journal of molecular sciences
|June 10, 2023
概括
使用循环瘤DNA (ctDNA) 的液体活检显示出早期胃癌诊断,最小残留疾病 (MRD) 监测和指导治疗的前景. 标准化对于临床采用至关重要.
科学领域:
- 在瘤学瘤学.
- 分子诊断学 分子诊断
- 基因组学就是基因组学.
背景情况:
- 胃癌 (GC) 由于其侵略性和预后不佳而构成重大挑战.
- 在GC中有限的可向的变化需要创新的诊断和监测方法.
- 液体活检为癌症评估提供了传统组织活检的不那么侵入性的替代方案.
研究的目的:
- 审查循环瘤DNA (ctDNA) 在胃腺癌中的当前和未来应用.
- 探索ctDNA在早期诊断,最小残留疾病 (MRD) 检测和高级疾病管理中的作用.
- 要突出需要在临床实施液体活检技术的标准化.
主要方法:
- 对胃癌中ctDNA应用的当前文献的综述.
- 分析ctDNA在GC不同阶段的预后价值.
- 讨论液体活检的预分析和分析考虑.
主要成果:
- 在胃癌的各个阶段,ctDNA 已被证明具有预后意义.
- 液体活检使瘤负担和分子变化的纵向监测成为可能.
- 潜在的应用包括早期检测,MRD评估和治疗选择/监测.
结论:
- ctDNA具有改变胃癌管理的巨大潜力.
- 预分析和分析程序的标准化和验证至关重要.
- 需要进一步的研究,以将液体活检纳入常规临床实践.
相关概念视频
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...


